{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T08:01:53Z","timestamp":1781078513787,"version":"3.54.1"},"reference-count":87,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>(1) Background and Objectives: Parkinson\u2019s disease\u2019s (PD) underlying pathophysiology still remains incompletely understood, with Braak\u2019s hypothesis of ASyn pathology propagation being the most widely accepted. Recently, a novel model has been introduced, proposing two distinct ASyn propagation pathways: a bottom-up trajectory termed Body-first PD, and a central nervous system (CNS)-initiated pathway termed Brain-first PD. This distinction introduces new perspectives in the PD literature landscape regarding diagnosis, prognostic factors and patient management. This study set out to systematically synthesize the current literature comparing Brain-first and Body-first PD, with a focus on clinical characteristics and disease progression, diagnostic biomarkers, and management approaches. (2) Materials and Methods: A systematic literature search was conducted in March 2025 using PubMed, Cochrane Library, DOAJ and Google Scholar. Human observational, diagnostic, and interventional studies published between 2019 and March 2025, including patients with de novo or early PD, were eligible. Pre-motor REM sleep behavioral disorder (RBD) was used as the primary differentiation criterion. Risk of bias was evaluated using the Joanna Briggs Institute (JBI) critical appraisal checklists. Results were synthesized using a narrative approach. (3) Results: Sixteen studies comprising 2107 PD patients met the inclusion criteria. Body-first PD was associated with a higher non-motor symptom (NMS) burden, faster disease progression, and a higher prevalence of cognitive impairment. Additionally, Body-first PD patients exhibited more widespread and symmetrical neurodegeneration, along with electrophysiological and metabolic differences. Distinct biomarker and microbiome profiles were also observed between subtypes. No eligible studies addressing management approaches were identified. (4) Conclusions: In conclusion, the available evidence suggests that Brain-first and Body-first PD may represent two distinct pathophysiological entities, a proposal with great significance for the diagnosis, prognosis and management of PD patients. However, the predominantly cross-sectional nature of the current literature limits causal inference. Future longitudinal and interventional studies are required to clarify the potential clinical implications of this subtype classification theory.<\/jats:p>","DOI":"10.3390\/medicina62061116","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T16:25:16Z","timestamp":1780935916000},"page":"1116","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["\u201cBrain-First\u201d vs. \u201cBody-First\u201d PD: Definitions and Implications in Everyday Clinical Practice: A Systematic Review"],"prefix":"10.3390","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-6986-5893","authenticated-orcid":false,"given":"Ioannis","family":"Pilateris","sequence":"first","affiliation":[{"name":"Department of Neurology, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece"},{"name":"\u201cKAT\u201d Attica General Hospital, 14561 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevasti","family":"Bostanjopoulou","sequence":"additional","affiliation":[{"name":"Department of Neurology, Aristotle University of Thessaloniki, George Papanikolaou Hospital, 57010 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.parkreldis.2004.01.005","article-title":"Inflammation and neurodegeneration in Parkinson\u2019s disease","volume":"10","author":"McGeer","year":"2004","journal-title":"Park. Relat. Disord."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jphs.2020.07.011","article-title":"Glutamate-induced excitotoxicity in Parkinson\u2019s disease: The role of glial cells","volume":"144","author":"Iovino","year":"2020","journal-title":"J. Pharmacol. Sci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"501","DOI":"10.5603\/pjnns.109238","article-title":"Importance of hypoglycemia episodes and glycemic variability in parkinsonian syndromes","volume":"59","author":"Alster","year":"2025","journal-title":"Neurol. Neurochir. Pol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"101834","DOI":"10.1016\/j.arr.2022.101834","article-title":"Premotor, nonmotor and motor symptoms of Parkinson\u2019s Disease: A new clinical state of the art","volume":"84","author":"Sallem","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/mds.23609","article-title":"A critical appraisal of the premotor symptoms of Parkinson\u2019s disease: Potential usefulness in early diagnosis and design of neuroprotective trials","volume":"26","author":"Lang","year":"2011","journal-title":"Mov. Disord."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/S1353-8020(09)70831-4","article-title":"The clinical progression of Parkinson\u2019s disease","volume":"15","author":"Poewe","year":"2009","journal-title":"Park. Relat. Disord."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00401-008-0346-6","article-title":"Applicability of current staging\/categorization of alpha-synuclein pathology and their clinical relevance","volume":"115","author":"Parkkinen","year":"2008","journal-title":"Acta Neuropathol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00702-018-1898-9","article-title":"Is Braak staging valid for all types of Parkinson\u2019s disease?","volume":"126","author":"Jellinger","year":"2019","journal-title":"J. Neural Transm."},{"key":"ref_10","first-page":"S281","article-title":"Brain-First versus Gut-First Parkinson\u2019s Disease: A Hypothesis","volume":"9","author":"Borghammer","year":"2019","journal-title":"J. Park. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"105557","DOI":"10.1016\/j.nbd.2021.105557","article-title":"Neuropathological evidence of body-first vs. brain-first Lewy body disease","volume":"161","author":"Borghammer","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"105626","DOI":"10.1016\/j.nbd.2022.105626","article-title":"Clinical and imaging evidence of brain-first and body-first Parkinson\u2019s disease","volume":"164","author":"Horsager","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"ref_13","first-page":"455","article-title":"The \u03b1-Synuclein Origin and Connectome Model (SOC Model) of Parkinson\u2019s Disease: Explaining Motor Asymmetry, Non-Motor Phenotypes, and Cognitive Decline","volume":"11","author":"Borghammer","year":"2021","journal-title":"J. Park. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/NNE.0b013e3181ed81e4","article-title":"Zotero: Harnessing the power of a personal bibliographic manager","volume":"35","author":"Coar","year":"2010","journal-title":"Nurse Educ."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst. Rev."},{"key":"ref_17","unstructured":"Parkinson Progression Marker Initiative (2011). The Parkinson Progression Marker Initiative (PPMI). Prog. Neurobiol., 95, 629\u2013635."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/XEB.0000000000000064","article-title":"Conducting systematic reviews of association (etiology): The Joanna Briggs Institute\u2019s approach","volume":"13","author":"Moola","year":"2015","journal-title":"Int. J. Evid. Based Healthc."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jclinepi.2010.09.011","article-title":"GRADE guidelines: A new series of articles in the Journal of Clinical Epidemiology","volume":"64","author":"Guyatt","year":"2011","journal-title":"J. Clin. Epidemiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1007\/s00415-023-11659-5","article-title":"Influence of RBD onset on the clinical characteristics of Parkinson\u2019s disease patients: A retrospective study","volume":"270","author":"Cicero","year":"2023","journal-title":"J. Neurol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41531-025-00874-8","article-title":"Clinically probable RBD is an early predictor of malignant non-motor Parkinson\u2019s disease phenotypes","volume":"11","author":"Hutchinson","year":"2025","journal-title":"npj Park. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/s41531-024-00730-1","article-title":"Disease progression in proposed brain-first and body-first Parkinson\u2019s disease subtypes","volume":"10","author":"Xu","year":"2024","journal-title":"npj Park. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1093\/brain\/awaa238","article-title":"Brain-first versus body-first Parkinson\u2019s disease: A multimodal imaging case-control study","volume":"143","author":"Horsager","year":"2020","journal-title":"Brain"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41531-023-00532-x","article-title":"Disruption of locus coeruleus-related functional networks in Parkinson\u2019s disease","volume":"9","author":"Sun","year":"2023","journal-title":"npj Park. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1002\/mds.29172","article-title":"Gray Matter Volume Loss in Proposed Brain-First and Body-First Parkinson\u2019s Disease Subtypes","volume":"37","author":"Banwinkler","year":"2022","journal-title":"Mov. Disord."},{"key":"ref_26","first-page":"1677","article-title":"Asymmetric Dopaminergic Dysfunction in Brain-First versus Body-First Parkinson\u2019s Disease Subtypes","volume":"11","author":"Knudsen","year":"2021","journal-title":"J. Park. Dis."},{"key":"ref_27","first-page":"823","article-title":"Symmetric and Profound Monoaminergic Degeneration in Par-kinson\u2019s Disease with Premotor REM Sleep Behavior Disorder","volume":"14","author":"Woo","year":"2024","journal-title":"J. Park. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/mds.30071","article-title":"Cortical Functional Connectivity Changes in the Body-First and Brain-First Subtypes of Parkinson\u2019s Disease","volume":"40","author":"Conti","year":"2025","journal-title":"Mov. Disord."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s00702-024-02809-8","article-title":"Quantitative EEG in Parkinson\u2019s disease: When REM sleep behavior disorder onset really matters","volume":"131","author":"Terranova","year":"2024","journal-title":"J. Neural Transm."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00415-024-12799-y","article-title":"Exploring the relation between REM sleep behavior disorder onset and striatal dopaminergic dysfunction in Parkinson\u2019s Disease","volume":"272","author":"Cicero","year":"2024","journal-title":"J. Neurol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"106655","DOI":"10.1016\/j.nbd.2024.106655","article-title":"Difference in gut microbial dysbiotic patterns between body-first and brain-first Parkinson\u2019s disease","volume":"201","author":"Park","year":"2024","journal-title":"Neurobiol. Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/s41531-025-00898-0","article-title":"Plasma GFAP and NfL associate with cerebral glucose metabolism in putative brain-first and body-first Parkinson\u2019s disease subtypes","volume":"11","author":"Li","year":"2025","journal-title":"npj Park. Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/s41531-024-00844-6","article-title":"Comparison of vagus nerve cross-sectional area between brain-first and body-first Parkinson\u2019s disease","volume":"10","author":"Dong","year":"2024","journal-title":"npj Park. Dis."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e16497","DOI":"10.1111\/ene.16497","article-title":"Urodynamic study and its correlation with cardiac meta-iodobenzylguanidine (MIBG) in body-first and brain-first subtypes of Parkinson\u2019s disease","volume":"31","author":"Kim","year":"2024","journal-title":"Eur. J. Neurol."},{"key":"ref_35","unstructured":"Duan, Q., Feng, S., Cen, H., Li, Y., Zhang, J., He, P., Zhang, Q., Qiu, Y., Gao, Y., and Ma, G. (2025, March 07). Gut Microbiota Dysbiosis and Bile Acids Alteration Associated in Parkinson\u2019s Disease with REM Sleep Behavior Disorder. SSRN [Preprint], Available online: https:\/\/ssrn.com\/abstract=4509506."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: A clini-co-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson\u2019s disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1002\/mds.21740","article-title":"The REM sleep behavior disorder screening questionnaire\u2014A new diagnostic instrument","volume":"22","author":"Mayer","year":"2007","journal-title":"Mov. Disord."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/mds.25037","article-title":"A single-question screen for rapid eye movement sleep behavior disorder: A multicenter validation study","volume":"27","author":"Postuma","year":"2012","journal-title":"Mov. Disord."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/mds.29407","article-title":"Low Specificity of Rapid Eye Movement Sleep Behavior Disorder Questionnaires: Need for Better Screening Methods","volume":"38","author":"Stefani","year":"2023","journal-title":"Mov. Disord."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/mdc3.12591","article-title":"The REM Sleep Behavior Disorder Screening Questionnaire is not Valid in De Novo Parkinson\u2019s Disease","volume":"5","author":"Halsband","year":"2018","journal-title":"Mov. Disord. Clin. Pract."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Lee, S., Kim, J., Baek, J., Jung, K., Lee, Y., Koh, A., and Kim, H. (2024). Untargeted plasma metabolomics unveils distinct metabolite profiles in Parkinson\u2019s disease subtypes: A focus on idiopathic REM sleep behavior disorder. bioRxiv.","DOI":"10.1101\/2024.05.02.592293"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"6452","DOI":"10.1007\/s00415-022-11294-6","article-title":"Associated factors and abnormal dorsal raphe nucleus connectivity patterns of freezing of gait in Parkinson\u2019s disease","volume":"269","author":"Lv","year":"2022","journal-title":"J. Neurol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.parkreldis.2015.04.005","article-title":"Structural and functional neuroimaging in patients with Parkinson\u2019s disease and visual hallucinations: A critical review","volume":"21","author":"Lenka","year":"2015","journal-title":"Park. Relat. Disord."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Chambers, N.E., Lanza, K., and Bishop, C. (2020). Pedunculopontine Nucleus Degeneration Contributes to Both Motor and Non-Motor Symptoms of Parkinson\u2019s Disease. Front. Pharmacol., 10.","DOI":"10.3389\/fphar.2019.01494"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3348\/kjr.2022.0712","article-title":"Neuroanatomical Localization of Rapid Eye Movement Sleep Behavior Disorder in Human Brain Using Lesion Network Mapping","volume":"24","author":"Yuan","year":"2023","journal-title":"Korean J. Radiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/brain\/aww006","article-title":"The coeruleus\/subcoeruleus complex in idiopathic rapid eye movement sleep behaviour disorder","volume":"139","author":"Ehrminger","year":"2016","journal-title":"Brain"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.sleep.2014.04.009","article-title":"Parkinson\u2019s disease and REM sleep behavior disorder result in increased non-motor symptoms","volume":"15","author":"Neikrug","year":"2014","journal-title":"Sleep Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1002\/mds.20582","article-title":"Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Par-kinson\u2019s disease","volume":"20","author":"Pacchetti","year":"2005","journal-title":"Mov. Disord."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1002\/mds.22099","article-title":"Manifestations of Parkinson disease differ in association with REM sleep behavior disorder","volume":"23","author":"Postuma","year":"2008","journal-title":"Mov. Disord."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1007\/s00415-011-6407-0","article-title":"Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients","volume":"259","author":"Erro","year":"2012","journal-title":"J. Neurol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1017\/cjn.2017.239","article-title":"Nonmotor Symptoms of Parkinson\u2019s Disease as Predictors of Dementia","volume":"45","author":"Hussain","year":"2018","journal-title":"Can. J. Neurol. Sci."},{"key":"ref_53","first-page":"452","article-title":"Association of Cognitive Behavior and Non-Motor Manifestations in Parkinson\u2019s Disease","volume":"5","author":"Hasnain","year":"2025","journal-title":"Heal. J. Physiother. Rehabil. Sci."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Prell, T. (2018). Structural and Functional Brain Patterns of Non-Motor Syndromes in Parkinson\u2019s Disease. Front. Neurol., 9.","DOI":"10.3389\/fneur.2018.00138"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/mds.28945","article-title":"Locus Coeruleus Shows a Spatial Pattern of Structural Disintegration in Parkinson\u2019s Disease","volume":"37","author":"Madelung","year":"2022","journal-title":"Mov. Disord."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"102873","DOI":"10.1016\/j.nicl.2021.102873","article-title":"Locus coeruleus degeneration is associated with disorganized functional topology in Parkinson\u2019s disease","volume":"32","author":"Zhou","year":"2021","journal-title":"NeuroImage Clin."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"9799","DOI":"10.1523\/JNEUROSCI.1787-16.2017","article-title":"Parkinson\u2019s Disease Is Not Simply a Prion Disorder","volume":"37","author":"Surmeier","year":"2017","journal-title":"J. Neurosci."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.cpet.2009.12.004","article-title":"FDG PET in the Evaluation of Parkinson\u2019s Disease","volume":"5","author":"Poston","year":"2010","journal-title":"PET Clin."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.clinph.2025.01.001","article-title":"The role of the somatosensory cortex in self-paced movement impairment in Parkinson\u2019s disease","volume":"171","author":"Alster","year":"2025","journal-title":"Clin. Neurophysiol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41531-023-00602-0","article-title":"Resting-state EEG measures cognitive impairment in Parkinson\u2019s disease","volume":"10","author":"Anjum","year":"2024","journal-title":"npj Park. Dis."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1212\/WNL.0000000000006473","article-title":"Clinical cor-relates of quantitative EEG in Parkinson disease: A systematic review","volume":"91","author":"Geraedts","year":"2018","journal-title":"Neurology"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/ana.10547","article-title":"Slowing of electroencephalogram in rapid eye movement sleep behavior disorder","volume":"53","author":"Fantini","year":"2003","journal-title":"Ann. Neurol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13195-020-00613-6","article-title":"EEG alpha reactivity and cholinergic system integrity in Lewy body dementia and Alzheimer\u2019s disease","volume":"12","author":"Schumacher","year":"2020","journal-title":"Alzheimers Res. Ther."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/bs.pbr.2022.01.011","article-title":"Cholinergic systems, atten-tional-motor integration, and cognitive control in Parkinson\u2019s disease","volume":"269","author":"Albin","year":"2022","journal-title":"Prog. Brain Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.nbd.2018.08.017","article-title":"The pedunclopontine nucleus and Parkinson\u2019s disease","volume":"128","author":"Tubert","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Molina, R., Hass, C.J., Sowalsky, K., Schmitt, A.C., Opri, E., Roper, J.A., Martinez-Ramirez, D., Hess, C.W., Foote, K.D., and Okun, M.S. (2020). Neurophysiological Correlates of Gait in the Human Basal Ganglia and the PPN Region in Parkinson\u2019s Disease. Front. Hum. Neurosci., 14.","DOI":"10.3389\/fnhum.2020.00194"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jns.2011.09.030","article-title":"Autonomic involvement in Parkinson\u2019s disease: Pathology, pathophysiology, clinical features and possible peripheral biomarkers","volume":"313","author":"Cersosimo","year":"2012","journal-title":"J. Neurol. Sci."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"fcad006","DOI":"10.1093\/braincomms\/fcad006","article-title":"Vagal cross-sectional area correlates with parasympathetic dysfunction in Parkinson\u2019s disease","volume":"5","author":"Huckemann","year":"2023","journal-title":"Brain Commun."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1759091420981206","DOI":"10.1177\/1759091420981206","article-title":"Regulation of GFAP Expression","volume":"13","author":"Brenner","year":"2021","journal-title":"ASN Neuro"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"100724","DOI":"10.1016\/j.medj.2025.100724","article-title":"Longitudinal progression of blood biomarkers reveals a key role of reactive astrocytosis in preclinical Alzheimer\u2019s disease","volume":"6","author":"Varma","year":"2025","journal-title":"Med"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.parkreldis.2021.07.028","article-title":"Serum neurofilament is associated with motor function, cognitive decline and subclinical cardiac damage in advanced Par-kinson\u2019s disease (MARK-PD)","volume":"90","author":"Niemann","year":"2021","journal-title":"Park. Relat. Disord."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/mds.28056","article-title":"CSF NFL in a Longitudinally Assessed PD Cohort: Age Effects and Cognitive Trajectories","volume":"35","author":"Lerche","year":"2020","journal-title":"Mov. Disord."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1159\/000235851","article-title":"Inflammation in the intestinal tract: Pathogenesis and treatment","volume":"27","author":"Blumberg","year":"2009","journal-title":"Dig. Dis."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Mou, Y., Du, Y., Zhou, L., Yue, J., Hu, X., Liu, Y., Chen, S., Lin, X., Zhang, G., and Xiao, H. (2022). Gut Microbiota Interact with the Brain Through Systemic Chronic Inflammation: Implications on Neuroinflammation, Neurodegeneration, and Aging. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.796288"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1146\/annurev-biochem-071322-021330","article-title":"Polyamines in Parkinson\u2019s Disease: Balancing Between Neurotoxicity and Neuroprotection","volume":"92","author":"Vrijsen","year":"2023","journal-title":"Annu. Rev. Biochem."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Fusco, W., Lorenzo, M.B., Cintoni, M., Porcari, S., Rinninella, E., Kaitsas, F., Lener, E., Mele, M.C., Gasbarrini, A., and Collado, M.C. (2023). Short-Chain Fatty-Acid-Producing Bacteria: Key Components of the Human Gut Microbiota. Nutrients, 15.","DOI":"10.3390\/nu15092211"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41575-019-0157-3","article-title":"The role of short-chain fatty acids in microbiota-gut-brain commu-nication","volume":"16","author":"Dalile","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1007\/s11739-023-03343-3","article-title":"The interaction of bile acids and gut inflammation influences the path-ogenesis of inflammatory bowel disease","volume":"18","author":"Bonfrate","year":"2023","journal-title":"Intern. Emerg. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.chom.2022.02.004","article-title":"Gut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis","volume":"30","author":"Cai","year":"2022","journal-title":"Cell Host Microbe"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jalz.2018.07.217","article-title":"Altered bile acid profile associates with cognitive impairment in Alzheimer\u2019s disease-An emerging role for gut microbiome","volume":"15","author":"MahmoudianDehkordi","year":"2019","journal-title":"Alzheimers Dement."},{"key":"ref_81","first-page":"203","article-title":"The gut-brain axis: Interactions between enteric microbiota, central and enteric nervous systems","volume":"28","author":"Carabotti","year":"2015","journal-title":"Ann. Gastroenterol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"6941","DOI":"10.1007\/s12035-019-1572-8","article-title":"The Impact of Chronic Intestinal Inflammation on Brain Disorders: The Microbio-ta-Gut-Brain Axis","volume":"56","author":"Serra","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Qu, S., Zheng, Y., Huang, Y., Feng, Y., Xu, K., Zhang, W., Wang, Y., Nie, K., and Qin, M. (2023). Excessive consumption of mucin by over-colonized Akkermansia muciniphila promotes intestinal barrier damage during malignant intestinal environment. Front. Microbiol., 14.","DOI":"10.3389\/fmicb.2023.1111911"},{"key":"ref_84","first-page":"3","article-title":"E. coli as an all-rounder: The thin line between commensalism and pathogenicity","volume":"358","author":"Leimbach","year":"2013","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2217\/fmb-2016-0130","article-title":"Roseburia spp.: A marker of health?","volume":"12","author":"Smida","year":"2017","journal-title":"Future Microbiol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2519695","DOI":"10.1080\/19490976.2025.2519695","article-title":"The Microbial Anti-Inflammatory Molecule (MAM) is a key protein processed and exported to Faecalibacterium duncaniae envelope","volume":"17","author":"Marthey","year":"2025","journal-title":"Gut Microbes"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Alster, P., Madetko, N., Koziorowski, D., and Friedman, A. (2020). Progressive Supranuclear Palsy-Parkinsonism Predominant (PSP-P)-A Clinical Challenge at the Boundaries of PSP and Parkinson\u2019s Disease (PD). Front. Neurol., 11.","DOI":"10.3389\/fneur.2020.00180"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/6\/1116\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T07:38:26Z","timestamp":1781077106000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/6\/1116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":87,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["medicina62061116"],"URL":"https:\/\/doi.org\/10.3390\/medicina62061116","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]}}}